Stanford Medcast Episode 88: Pediatric Pulse Mini-Series - Transforming Pediatric Cancer Care: What’s Next?

Dr. Crystal Mackall, the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University, will be joining us today to discuss childhood cancer during September’s Childhood Cancer Awareness Month. Dr. Mackall will share insights into her journey in pediatric oncology, focusing on pediatric cancer research. Our conversation will delve into the disparities between advancements in adult cancer treatment versus the limited progress in pediatric cancer care. Topics will include the current landscape of pediatric cancer, common types affecting children, distinctions from adult cancers, access to care, ongoing research initiatives, challenges in addressing certain diseases, and upcoming clinical trials.

To Claim Credit for listening to this episode:
1.Go to 'Begin' and then click on 'Claim CE.'
2.Follow prompts to complete an evaluation.
3.Credit hours will be reflected on your transcript, or you may download your certificate.

1. Discuss the differences between adult and pediatric cancers.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the CME Office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
1.National Cancer Institute. (2019). Childhood Cancers. National Cancer Institute; Cancer.gov. https://www.cancer.gov/types/childhood-cancers
2.National Cancer Institute. (2024, August 5). T-cell transfer therapy - immunotherapy. Immunotherapy - NCI. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy
3.Ramakrishna, S., Barsan, V., & Mackall, C. (2020). Prospects and challenges for use of CAR T cell therapies in solid tumors. Expert opinion on biological therapy, 20(5), 503–516. https://doi.org/10.1080/14712598.2020.1738378

For activity related questions, please contact
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ruth Adewuya, MD
Managing Director
Stanford University

Course Director and Reviewer

Nothing to disclose

Crystal Lee Mackall, MD
Professor of Pediatrics (Hematology/Oncology) and of Medicine
Stanford University School of Medicine

Faculty

Stocks or stock options, excluding diversified mutual funds-CARGO Therapeutics|Stocks or stock options, excluding diversified mutual funds-Lyell Immunopharma (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-LINK Cell Therapies|Stocks or stock options, excluding diversified mutual funds-GBMNewCo|Advisor-Ensoma|Paid consultant-CARGO Therapeutics|Paid consultant-Lyell Immunopharma (Relationship has ended)|Paid consultant-GBMNewCo|Paid consultant-Ensoma|Paid consultant-Immatics|Grant or research support-Lyell Immunopharma (Relationship has ended)|Grant or research support-Tune Therapeutics

Lydia Wang
Medcast Intern
Stanford

Planner

Nothing to disclose